Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page

Markus Hoffmann

dblp:65/659 · DBLP profile ↗
← Back
2ranked-venue papers
0as first author
2since 2021 · last 2023
0000-0002-1920-288XORCID · corroborated

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 2 · 2 since 2021

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
2 papers
Bioinformatics and computational biology · 85% Medical and health informatics · 15%

Topics — the 7 heaviest of 7, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology
biomarker discovery
0.712023
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape · Bioinform. 2023
Bioinformatics and computational biology
cancer genomics
0.712023
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape · Bioinform. 2023
Bioinformatics and computational biology › biological network › network biology
competing endogenous RNA network
0.712023
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape · Bioinform. 2023
Bioinformatics and computational biology › gene regulation › gene regulatory network
gene regulatory network analysis
0.712023
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape · Bioinform. 2023
Medical and health informatics › precision medicine
patient stratification
0.712023
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape · Bioinform. 2023
Bioinformatics and computational biology › genomics › genome-wide association study
epistasis detection
0.512021
A framework for modeling epistatic interaction · Bioinform. 2021
Bioinformatics and computational biology › genomics
genome-wide association study
0.512021
A framework for modeling epistatic interaction · Bioinform. 2021

Methods — techniques the papers use, named apart from their topics

machine learning · 0.7quadratic regression · 0.5maximum likelihood · 0.5chi-squared test · 0.5
YearPublicationVenuePosition
2023 spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape
abstract
MOTIVATION: Cancer is one of the leading causes of death worldwide. Despite significant improvements in prevention and treatment, mortality remains high for many cancer types. Hence, innovative methods that use molecular data to stratify patients and identify biomarkers are needed. Promising biomarkers can also be inferred from competing endogenous RNA (ceRNA) networks that capture the gene-miRNA gene regulatory landscape. Thus far, the role of these biomarkers could only be studied globally but not in a sample-specific manner. To mitigate this, we introduce spongEffects, a novel method that infers subnetworks (or modules) from ceRNA networks and calculates patient- or sample-specific scores related to their regulatory activity. RESULTS: We show how spongEffects can be used for downstream interpretation and machine learning tasks such as tumor classification and for identifying subtype-specific regulatory interactions. In a concrete example of breast cancer subtype classification, we prioritize modules impacting the biology of the different subtypes. In summary, spongEffects prioritizes ceRNA modules as biomarkers and offers insights into the miRNA regulatory landscape. Notably, these module scores can be inferred from gene expression data alone and can thus be applied to cohorts where miRNA expression information is lacking. AVAILABILITY AND IMPLEMENTATION: https://bioconductor.org/packages/devel/bioc/html/SPONGE.html.
Fabio Boniolo, Markus Hoffmann, Norman Roggendorf, Bahar Tercan, Jan Baumbach, Mauro A. A. Castro, Gordon Robertson, Dieter Saur, Markus List
Bioinform.2
2021 A framework for modeling epistatic interaction
abstract
MOTIVATION: Recently, various tools for detecting single nucleotide polymorphisms (SNPs) involved in epistasis have been developed. However, no studies evaluate the employed statistical epistasis models such as the χ2-test or quadratic regression independently of the tools that use them. Such an independent evaluation is crucial for developing improved epistasis detection tools, for it allows to decide if a tool's performance should be attributed to the epistasis model or to the optimization strategy run on top of it. RESULTS: We present a protocol for evaluating epistasis models independently of the tools they are used in and generalize existing models designed for dichotomous phenotypes to the categorical and quantitative case. In addition, we propose a new model which scores candidate SNP sets by computing maximum likelihood distributions for the observed phenotypes in the cells of their penetrance tables. Extensive experiments show that the proposed maximum likelihood model outperforms three widely used epistasis models in most cases. The experiments also provide valuable insights into the properties of existing models, for instance, that quadratic regression perform particularly well on instances with quantitative phenotypes. AVAILABILITY AND IMPLEMENTATION: The evaluation protocol and all compared models are implemented in C++ and are supported under Linux and macOS. They are available at https://github.com/baumbachlab/genepiseeker/, along with test datasets and scripts to reproduce the experiments. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
David B. Blumenthal, Jan Baumbach, Markus Hoffmann, Tim Kacprowski, Markus List
Bioinform.3